Jimee Hwang

TL;DR: The shift in the populations most at risk of malaria raises important questions for malaria-eliminating countries, since traditional control interventions are likely to be less effective.

TL;DR: Evidence about the technical, operational, and financial dimensions of malaria elimination is presented, including challenges and risks of elimination, including Plasmodium vivax, resistance in the parasite and mosquito populations, and potential resurgence if investment and vigilance decrease.

TL;DR: The issues faced and the solutions found in developing this robust strategic partnership between national programmes and research partners within the APMEN Vivax Working Group are described.

TL;DR: A systematic, qualitative review of published, unpublished, and gray literature documenting past MDA experiences suggests that MDA has been used successfully to control and eliminate Plasmodium falciparum and P. vivax malaria in the past, and should be considered as part of a comprehensive malaria elimination strategy in specific settings.

TL;DR: This review aims to summarize the findings from existing research studies and program experiences of MDA strategies for reducing malaria burden and transmission and assess the impact of antimalarial MDA on population asexual parasitaemia prevalence, Parasitaemia incidence, gametocytaemia prevalence), anaemia prevalence and mortality and MDA‐associated adverse events.